India In-Vitro Diagnostics Market is predicted to reach USD 4.40 Billion by 2030

According to the study by Next Move Strategy Consulting, the India In-Vitro Diagnostics Market size is predicted to reach USD 4.40 billion, at a CAGR of 7.17% by 2030.

Request a FREE Sample: https://www.nextmsc.com/india-in-vitro-diagnostics-market/request-sample

The robust growth of the medical device industry in the country serves as a key driver for the India in-vitro diagnostics market expansion.

The prevalence of cancer in the country significantly drives the India in-vitro diagnostics market growth.

The promising players operating in the India in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.